ListedSMEPharmaceuticals & DrugsANL
Accretion Nutraveda IPO
Accretion Nutraveda IPO is an SME IPO raising ₹25 Cr at ₹122 – ₹129 a share. It listed on 4 Feb 2026 at ₹191, +48.1% against its issue price of ₹129, and trades at ₹270 today (+109.3% since issue). It was subscribed 1.33× in total.
₹129
Issue price
₹270
Price now
+109.3%
Since issue price
4 Feb 2026
Listed on
1.33×Subscribed (final) · all exchanges
Just covered — bids slightly exceed the shares on offer
populated partly populated we hold nothing here — the tab says why
We hold no bidding data for this issue
We could not retrieve a category split for this issue. It may have listed only on BSE — our category data comes from NSE, which is blind to BSE-only issues — or the exchange may no longer serve its bidding archive.
Category split (QIB / non-institutional / retail)not held
Price-point demand curvenot held
Total subscription figureheld